Holding(s) in Company

TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached:

Surgical Innovations Group plc  


2. Reason for the notification (please state Yes/No): (    )

An acquisition or disposal of voting rights: (YES)

An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached: (NO)

An event changing the breakdown of voting rights: (NO)


3. Full name of person(s) subject to the notification obligation:

Deutsche Bank AG                     
 

4. Full name of shareholder(s) (if different from 3):

Tilney Group Ltd
DWS Investment GmbH
 

5. Date of the transaction (and date on which the threshold is crossed or
reached if different):

12 June 2007       


6. Date on which issuer notified:

18 June 2007                   
      
 
7. Threshold(s) that is/are crossed or reached:

3,4,5,6,7,8%


8. Notified details:

A: Voting rights attached to shares

Class/type   Situation of previous   Resulting Situation after the triggering  
of shares if   to the Triggering                   transaction                 
possible          transaction                                                  
using ISIN                                                                     
code          Number   Number of   Number of  Number of voting    % of voting  
                of       voting      shares        rights           rights     
              shares     rights                                                
                                                                               
                                              Direct  Indirect  Direct Indirect
                                                                               
GB0004016704   N/A        N/A      32,893,144   0    32,893,144   0      8.8%  
                                                                               

B: Financial Instruments

Resulting Situation after the triggering transaction                           
                                                                               
  Type of   Expiration  Exercise /    Number of Voting rights that may   % of  
 Financial     Date     Conversion    be acquired if the instrument is  voting 
Instrument             Period /Date        exercised / converted        rights 
                                                                               
                                                                             
                                                                        
Total (A + B)

Number of Voting Rights % of voting rights
                                          
      32,893,144              8.80%       
                                      

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable

N/A
   

Proxy Voting:

10. Name of the proxy holder:

N/A

 
11. Number of voting rights proxy holder will cease to hold:

N/A


12. Date on which proxy holder will cease to hold voting rights:

N/A


13. Additional information:

Please note that this is the first disclosure made on behalf of Deutsche Bank
AG and its subsidiary companies in relation to holdings in Surgical Innovations
Group plc since the implementation of the Disclosure and Transparency rules in
the UK


14. Contact name:

David Lindsay / Andrew Anderson


15. Contact telephone number:

020 7545 8533 / 020 7545 8532

 

Surgical Innovations Group plc                              
Graham Bowland (Finance Director)                 0113 230 7597           
                                  [e-mail]
                                                           
Hanson Westhouse Limited                          0113 246 2610
Tim Feather / Matthew Johnson